Literature DB >> 9196751

Invasion and growth of Plasmodium falciparum is inhibited in fractionated thalassaemic erythrocytes.

A C Senok1, K Li, E A Nelson, L M Yu, L P Tian, S J Oppenheimer.   

Abstract

Epidemiological and clinical studies have indicated that the thalassaemias may confer protection against malaria. The study reported here investigated this protective effect in vitro, using a new approach which controls for the potential effect of red cell size and age on the virulence of the parasite. A Percoll density gradient method was used to separate alpha- and beta-thalassaemic trait, haemoglobin H and normal red blood cells (RBC) into fractions of different density. Correlations between RBC density, age and size in fractions of all genotypes were established using red cell creatine as an index of cell age. The development of Plasmodium falciparum over 3 erythrocytic cycles (144 h) in whole blood as well as fractionated samples was monitored by slide microscopy and flow cytometry. A significantly reduced rate of parasite invasion and growth was demonstrated in RBC from all thalassaemic genotypes tested. Poor reinvasion rates were noted in the second and third cycles. Increased duration of culture and red cell age also had a greater negative impact on parasite growth in thalassaemic RBC. This poor growth rate was also associated with the arrest of parasite growth at the schizont stage (schizont maturation arrest) and the accumulation of abnormal, trophozoite/schizont stage parasites in the older thalassaemic RBC fractions. These findings suggest a defect in the number and viability of merozoites generated by parasites growing in thalassaemic RBC. Age related factors such as oxidant stress may play a key role in mediating this kind of protective mechanism and deserve further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196751     DOI: 10.1016/s0035-9203(97)90200-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum.

Authors:  Teresa Tiffert; Virgilio L Lew; Hagai Ginsburg; Miriam Krugliak; Laure Croisille; Narla Mohandas
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

2.  Ultrastructural assessment of Plasmodium falciparum in age-fractionated thalassaemic erythrocytes.

Authors:  A C Senok; E A S Nelson; K Li; A R Y Ismaeel; P Olliaro; S J Oppenheimer
Journal:  Parasitol Res       Date:  2005-12-15       Impact factor: 2.289

Review 3.  Out-of-Africa, the peopling of continents and islands: tracing uniparental gene trees across the map.

Authors:  Stephen Oppenheimer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

4.  Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

Authors:  W Ittarat; S Looareesuwan; P Pootrakul; P Sumpunsirikul; P Vattanavibool; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  alpha+-Thalassemia protects children against disease caused by other infections as well as malaria.

Authors:  S J Allen; A O'Donnell; N D Alexander; M P Alpers; T E Peto; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  AHSP: a novel hemoglobin helper.

Authors:  Arthur Bank
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 7.  World distribution, population genetics, and health burden of the hemoglobinopathies.

Authors:  Thomas N Williams; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

8.  Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia.

Authors:  Freya J I Fowkes; Stephen J Allen; Angela Allen; Michael P Alpers; David J Weatherall; Karen P Day
Journal:  PLoS Med       Date:  2008-03-18       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.